Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
Research
Research
Federal judge rules hundreds of NIH grant terminations unlawful
In response, HHS is exploring possible legal options, including filing an appeal or moving to stay the order.
Darren Incorvaia
Jun 16, 2025 5:55pm
Turkish bank invests $39M in Harvard next-gen obesity antibodies
Jun 16, 2025 1:07pm
Sponsored
Biologics Outsourcing: From Option to Imperative
Jun 13, 2025 8:00am
Senators grill NIH chief over proposed $18B cut
Jun 10, 2025 5:21pm
ASH launches $12M fund for scientists who lose federal grants
Jun 10, 2025 4:32pm
NIH staff urge director to reverse funding cuts, firings
Jun 9, 2025 4:33pm